| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Lyons Gary A is a Director at NEUROCRINE BIOSCIENCES INC with holdings across 4 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $25.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2022 | NBIX Neurocrine Biosciences Inc | Director | Sell | 5,000 | $110.54 | $552,711.00 | -2.4% | +9.9% | +1.3% | |
| Apr 25, 2022 | NBIX Neurocrine Biosciences Inc | Director | Sale+OE | 15,000 | $92.76 | $1,391,392.50 | -6.7% | +1.6% | +9.2% | |
| Oct 7, 2021 | NBIX Neurocrine Biosciences Inc | Director | Sell | 5,000 | $105.06 | $525,293.50 | -2.3% | -19.2% | +5.1% | |
| Jun 10, 2021 | NBIX Neurocrine Biosciences Inc | Director | Sell | 10,000 | $100.27 | $1,002,743.00 | -4.5% | -5.7% | -6.2% | |
| Jan 26, 2021 | NBIX Neurocrine Biosciences Inc | Director | Sell | 2,000 | $120.02 | $240,046.56 | -0.4% | - | - | |
| Nov 8, 2019 | NBIX Neurocrine Biosciences Inc | Director | Sell | 5,000 | $110.00 | $550,000.00 | -2.2% | - | - | |
| Nov 1, 2019 | NBIX Neurocrine Biosciences Inc | Director | Sell | 5,000 | $100.22 | $501,103.50 | -2.1% | - | - | |
| Jul 30, 2019 | NBIX Neurocrine Biosciences Inc | Director | Sell | 10,000 | $92.07 | $920,686.00 | -4.1% | - | - | |
| Nov 2, 2018 | NBIX Neurocrine Biosciences Inc | Director | Sell | 15,000 | $114.41 | $1,716,213.00 | -5.8% | - | - | |
| Jun 13, 2018 | NBIX Neurocrine Biosciences Inc | Director | Sell | 15,000 | $99.24 | $1,488,549.00 | -5.4% | - | - |